There are 2949 resources available
Discussion and closing remarks
Presenter: Jean-Yves Blay
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Welcome
Presenter: Bettina Ryll
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
The innovative early treatment landscape
Presenter: Nils Wilking
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Access, availability, and uptake of combination therapies in Europe
Presenter: Tim Wilsdon
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Panel discussion moderated by Bettina Ryll
Presenter: Deepak Khanna
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Expert insights: Adapting treatment during the COVID-19 pandemic
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Emerging long-term survival data and implications for clinical practice
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Studying survival: An evidence-based approach to improving outcomes
Presenter: Paolo Ascierto
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Summary and close
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Welcome and Introductions
Presenter: Martin Reck
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast